Radiation-induced urethral stricture is scar narrowing that can develop months or years after radiotherapy for prostate or pelvic cancer. It commonly affects the bulbomembranous urethra and can be more difficult to reconstruct because irradiated tissue has reduced blood supply and lies close to the urinary sphincter. Evaluation usually includes flow testing, urethral imaging and cystoscopy. Treatment may be endoscopic for selected non-obliterative narrowing, but recurrent or severe disease may require reconstruction with detailed counselling about continence.

What is a radiation-induced urethral stricture?

Radiation can progressively damage tissue microcirculation. Over time, fibrosis develops in and around the urethra and may narrow the urinary channel. The process is different from a simple mucosal cut because the surrounding tissues may also be fibrotic.

What patients commonly notice

• Gradually weakening flow years after radiotherapy.
• Straining or urinary retention.
• Repeated endoscopic incision with recurrence.
• Coexisting urgency, frequency or radiation cystitis symptoms.
• Urinary leakage that may become more noticeable when obstruction is relieved.

Why radiation strictures are different

Radiotherapy can cause progressive small-vessel injury and fibrosis. The affected tissue may have poorer blood supply and healing capacity than a simple traumatic scar. The narrowing often involves the bulbomembranous region close to the urinary sphincter, so restoring patency must be balanced with the risk of worsening urinary incontinence.

When can it appear?

Radiation injury can be delayed. A man may urinate well after radiotherapy and develop obstruction months or years later. Symptoms should therefore be assessed even when cancer treatment was remote.

What makes evaluation more complex?

• The bladder may also be affected by radiation, causing frequency, urgency or bleeding.
• The urinary sphincter may already be weakened by prostate surgery or radiation.
• Previous TURP, prostatectomy or repeated endoscopic treatment may have altered the anatomy.
• Complete obliteration behaves differently from a short non-obliterative stenosis.

Treatment: why one plan does not fit everyone

Selected short non-obliterative radiation-induced stenoses may be treated endoscopically, although recurrence can be substantial. Reconstructive surgery may be considered for recurrent or obliterative disease, but counselling must cover continence, tissue quality and the possibility that an artificial urinary sphincter or other continence treatment could be needed later.

Cancer surveillance still matters

New urinary obstruction after cancer treatment should not automatically be labelled “radiation stricture.” The treating team may also need to consider cancer recurrence, stones, bladder pathology and other causes depending on the clinical context.

Continence after radiation-stricture treatment

The urinary sphincter may already have been affected by prostatectomy, radiation or both. A tight bulbomembranous narrowing can sometimes reduce leakage by acting like unintended extra resistance. Once the obstruction is opened, underlying sphincter weakness can become more visible.

This does not mean obstruction should be left untreated simply to preserve continence. It means patency and continence may need to be managed in sequence. The urethral outlet is first stabilised; if bothersome stress incontinence remains, options such as an artificial urinary sphincter can be considered after the reconstructed area has demonstrated stability.

Radiation can also affect bladder capacity, urgency and bleeding, so a patent urethra may not eliminate every urinary symptom. Good counselling separates the expected effect on flow from the separate effects of bladder and sphincter radiation injury.

When should you see a urologist?

After pelvic radiotherapy, a new weak stream or retention should be assessed rather than assumed to be an ordinary age-related prostate problem. Radiation injury can appear years later and may coexist with bladder dysfunction, sphincter weakness, recurrent cancer or prior surgical scarring.

• Flow gradually worsens months or years after prostate/pelvic radiotherapy.
• Repeated endoscopic treatment has given only temporary relief.
• There is increasing residual urine, infection or retention.
• Urinary leakage is already present and obstruction is also suspected.
• Previous cancer surgery and radiotherapy have both affected the outlet.

Why radiation strictures are followed for longer

Radiation injury can evolve for years because small-vessel damage and progressive fibrosis continue long after cancer treatment has finished. A urethra that is satisfactory soon after treatment can therefore narrow later, and a reconstructed segment can also fail late.

Follow-up is not limited to the urethra. Haematuria may reflect radiation cystitis, recurrent tumour or another urinary cause; urgency may come from a reduced-capacity bladder; and incontinence may become apparent after the obstruction is relieved. Cancer surveillance continues according to the original prostate-cancer plan.

If an artificial urinary sphincter is eventually considered, reconstructive stability is usually demonstrated first. That sequencing reduces the need to repeatedly instrument across a continence device if the stenosis recurs.

How is urethral stricture diagnosed?

Evaluation has to map both the narrowing and the surrounding functional problem. Cystoscopy identifies the lumen and location; RGU/VCUG can define length and whether the bulbomembranous segment is obliterated. Uroflow/PVR quantify obstruction. The urologist also documents continence, prior TURP/prostatectomy, radiation modality and dose if available, and cancer status. When bladder compliance or contractility is uncertain, urodynamic assessment may change counselling.

Treatment options

Radiation-associated bulbomembranous strictures behave differently because fibrosis and reduced vascularity extend beyond the visible ring. The balance is between restoring patency and preserving continence in tissue that may heal less predictably.

Dilatation or VIU / DVIU

For a non-obliterative radiation-associated bulbomembranous narrowing, an initial visually controlled endoluminal treatment may be reasonable. Complete obliteration is not an endoscopic problem. Recurrent disease after multiple incisions should prompt a reconstructive discussion rather than assuming another cut will be durable.

Urethroplasty

Urethroplasty is feasible in selected patients but is technically demanding. Anastomotic or augmentation techniques may be used depending on length and tissue quality. Patients should specifically discuss recurrence, de novo or worsened incontinence, and the possibility that continence surgery may be considered only after the urethra is stable.

Urinary drainage when the patient cannot pass urine

Suprapubic diversion is useful for acute retention and can provide urethral rest before reconstruction. In complex radiated outlets it also allows antegrade assessment of the bladder neck when required.

Why bladder function matters before radiation-stricture reconstruction

Radiation can affect more than the urethral scar. The bladder may be smaller, less compliant or more irritable, and the urinary sphincter may already be weakened by previous prostate treatment. A technically open urethra does not automatically produce good urinary quality of life if the bladder stores poorly or the sphincter cannot maintain continence.

For that reason, reconstructive assessment may include continence history, cystoscopy, imaging and, in selected patients, bladder-function testing. The surgeon is planning two outcomes at the same time: reliable drainage and acceptable continence. Patients with significant pre-existing leakage should understand that opening a tight bulbomembranous stricture can unmask or worsen incontinence, and continence surgery may need to be considered later.

What current guidance says about reconstruction after radiation

Current EAU guidance recognises endoscopic treatment as a reasonable first approach for selected non-obliterative radiation-associated bulbomembranous stenosis, but complete obliteration is different. When endoscopic treatment fails and reconstruction is appropriate, short segments may be treated with excision and primary anastomosis or augmentation, while longer segments generally need augmentation urethroplasty.

Radiated tissue heals less predictably than non-radiated tissue. A successful reconstruction therefore depends on healthy vascularised edges, a tension-free repair and realistic counselling about recurrence, continence and erectile function rather than simply choosing the shortest operation.

What to bring for consultation

• Radiotherapy summary: cancer treated, approximate date and modality if known.
• Prostatectomy/TURP or other pelvic operative reports.
• Current cancer surveillance records such as PSA where relevant.
• RGU/VCUG and cystoscopy findings.
• Baseline continence/pad use and erectile-function history.
• Details of prior DVIU, dilatation, catheter or suprapubic drainage.

FAQs

Related reading

• Vesicourethral Anastomotic Stenosis After Radical Prostatectomy
• Recurrent Urethral Stricture: Why It Comes Back
• Redo Urethroplasty After Failed Surgery
• Urethroplasty Surgery Explained
• Urologist in Latur

References

• European Association of Urology. EAU Guidelines on Urethral Strictures, 2026 https://uroweb.org/guidelines/urethral-strictures
• European Association of Urology. EAU Guidelines on Urethral Strictures: Disease Management in Males, 2026 https://uroweb.org/guidelines/urethral-strictures/chapter/disease-management-in-males
• European Association of Urology. EAU Guidelines on Urethral Strictures: Diagnostic Evaluation, 2026 https://uroweb.org/guidelines/urethral-strictures/chapter/diagnostic-evaluation
• European Association of Urology. EAU Guidelines on Urethral Strictures: Follow-up, 2026 https://uroweb.org/guidelines/urethral-strictures/chapter/followup
• American Urological Association. Urethral Stricture Guideline (2023 amendment) https://www.auanet.org/guidelines-and-quality/guidelines/urethral-stricture-guideline